Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma

Epidermal growth factor receptor (EGFR) and EGFRvIII analysis is of current interest in glioblastoma – the most common malignant primary CNS tumor, because of new EGFRvIII vaccine trials underway. EGFR activation in glioblastoma promotes cellular proliferation via activation of MAPK and PI3K–Akt pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Padfield, Emily, Ellis, Hayley P., Kurian, Kathreena M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310282/
https://www.ncbi.nlm.nih.gov/pubmed/25688333
http://dx.doi.org/10.3389/fonc.2015.00005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310282/
https://www.ncbi.nlm.nih.gov/pubmed/25688333
http://dx.doi.org/10.3389/fonc.2015.00005

Ejemplares similares